Literature DB >> 11594547

Management of deep endometriosis.

C Chapron1, J B Dubuisson.   

Abstract

Deep endometriosis is defined as an endometriotic lesion that penetrates the retroperitoneal space for a distance of > or =5 mm. Deep endometriosis is extremely active, occurs in phase with eutopic endometrium, evolves progressively with age, and is most often located in the pouch of Douglas, the rectovaginal septum, the uterosacral ligaments, and occasionally in the uterovesical fold. These lesions are associated with pelvic pain, the intensity of which is proportional to the depth of penetration. It is clear that choice of treatment depends on the location of the endometriotic lesion. In this paper we describe our methods for the initial diagnosis and subsequent treatment of deep endometriosis. These include consultation and clinical examination protocols, use of rectal endoscopic ultrasonography (EUS), magnetic resonance imaging (MRI), and transvaginal ultrasonography techniques in diagnosis and surgical treatment approaches.

Entities:  

Mesh:

Year:  2001        PMID: 11594547     DOI: 10.1111/j.1749-6632.2001.tb03808.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Endometrioma of the large bowel.

Authors:  Venkata Kanthimathinathan; Ehab Elakkary; Wissam Bleibel; Nafisa Kuwajerwala; Srinivasulu Conjeevaram; Farouk Tootla
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.199

2.  Laparoscopic excision of endometriosis may require unilateral parametrectomy.

Authors:  S Landi; L Mereu; U Indraccolo; R Favero; A Fiaccavento; R Zaccoletti; R Clarizia; F Barbieri
Journal:  JSLS       Date:  2009 Oct-Dec       Impact factor: 2.172

3.  Serial assessment of inflammatory parameters for prediction of septic complications following surgery for colorectal endometriosis : A descriptive, retrospective study.

Authors:  Eliana Montanari; Lena Maria Reh; Bernhard Dauser; Tudor Birsan; Gernot Hudelist
Journal:  Wien Klin Wochenschr       Date:  2021-08-02       Impact factor: 1.704

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.